Krukenberg's tumor diagnosed in pregnancy is an uncommon situation that raises both
diagnosis and medical management issues. We performed a review of the existing literature …

Breast cancer diagnosed during pregnancy is at increasing incidence due to the increased
frequency of obesity, the postponement of the first pregnancy to later decades of life and the …

Prevalence of deleterious mutations among patients with breast cancer referred for multigene
panel testing in a Romanian population - PMC Back to Top Skip to main content NIH NLM …

Currently there is an increased number of genetic tests available for disorders produced by
chromosomal or gene abnormalities. Some genetic tests are recommended by healthcare …

Abstract Background Presence of Germline mutations in the BRCA 1 and BRCA 2 genes is
the most significant epidemiological factor for breast cancer (BC), where germline BRCA1 (g …

Simple Summary Multigene panel testing for Hereditary Breast and Ovarian Cancer using
next generation sequencing is the new standard for the identification of individuals with …

We present the clinical and pathological aspects of a patient diagnosed with a very rare
tumor, a blue nevus-like melanoma of the uterine cervix. The patient turned to our Service for …

Background: Hereditary breast cancers constitute around 5%–10% of all breast cancers.
The most commonly mutated genes in hereditary breast and ovarian cancer syndrome are …

Purpose: To assess the influence of reproductive factors in the occurrence of breast cancer
in women, taking into account the presence/absence of genetic predisposing mutations …

Hereditary predisposition to breast and ovarian cancer (HBOC) is diagnosed by molecular
analysis of deleterious mutations in BRCA genes, allowing oncogenetic follow-up of patients …